Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05701488
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Not Yet Recruiting
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
NCT07446257
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
NCT03222076
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anaplastic Astrocytoma, +137 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, Not Recruiting
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
NCT02379377
- Conditions
- Adenocarcinoma, Adult Hepatocellular Carcinoma, Benign Liver Tumor, +13 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer
NCT04856046
- Conditions
- Resectable Hepatocellular Carcinoma
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer
NCT04721132
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
NCT04857684
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States